David Pryor

13PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMedical roboticsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 24, 2026
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide With Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.

|Aug 26, 2024
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.

Muhammad Ali, Young Suk Kwon, Kendrick Koo

|Sep 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians.

Trent A Pattenden, Isaac A Thangasamy, Wee Loon Ong

|Feb 24, 2023
Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: An institutional experience.

Beini Chen, Nick Butler, Thomas O'Rourke

|Sep 10, 2021
Automatic radiotherapy delineation quality assurance on prostate MRI with deep learning in a multicentre clinical trial.

Hang Min, Jason Dowling, Michael G Jameson

|Aug 16, 2021
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes.

Mihir D Shanker, Pereshin Moodaley, Wei Soon

Pageof 3

Frequent Collaborators

3 joint publications

Howard Yu-Hao Liu

2 joint publications

Nathan Lawrentschuk

2 joint publications

Declan Murphy

2 joint publications

Jarad Martin